» Articles » PMID: 40087650

Characteristics, Management and Outcomes of Central Versus Peripheral Pulmonary Embolism: a Retrospective Cohort Study

Overview
Journal Thromb J
Publisher Biomed Central
Date 2025 Mar 15
PMID 40087650
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The location of thrombus in acute pulmonary embolism (PE) is a debatable prognostic factor. We compared the characteristics and outcomes of hospitalized patients with central versus peripheral PE.

Methods: This retrospective study evaluated patients with acute PE diagnosed by CT pulmonary angiography who were hospitalized between 01/01/2016 and 31/12/2022. We compared patients with central (pulmonary trunk/main pulmonary artery) and peripheral (lobar/segmental/subsegmental) PE.

Results: We studied 438 patients (median age: 63 years; PE diagnosis in the Emergency Department: 64.8%; PE peripheral in 305 patients [69.6%] and central in 133 [30.4%]). Patients with central PE had higher levels of troponin I and brain natriuretic peptide and more frequent right ventricular strain by CT pulmonary angiography/ echocardiography (72.1% versus 33.3%, p < 0.0001). PE mortality risk could be classified in 355 patients; 24.4% of the 238 patients with peripheral PE were intermediate-high/ high-risk compared with 63.3% of the 117 patients with central PE. Patients with central PE had more systemic thrombolysis (13/133 [9.8%] versus 6/305 [2.0%], p < 0.0001) and more advanced endovascular therapy (15/133 [11.3%] versus 2/305 [0.7%], p < 0.0001). All-cause hospital mortality rate was similar in patients with central and peripheral PE (5.3% and 6.6%, respectively; p = 0.61). On multivariable logistic regression analysis, central versus peripheral PE was not associated with hospital mortality (odds ratio 0.392, 95% confidence interval 0.128, 1.199).

Conclusions: The majority of patients with central PE and a minority of those with peripheral PE were classified as intermediate-high/ high-risk, however, the central thrombus location was not associated with an increased risk of mortality.

References
1.
Freund Y, Cohen-Aubart F, Bloom B . Acute Pulmonary Embolism: A Review. JAMA. 2022; 328(13):1336-1345. DOI: 10.1001/jama.2022.16815. View

2.
Konstantinides S, Meyer G, Becattini C, Bueno H, Geersing G, Harjola V . 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2019; 41(4):543-603. DOI: 10.1093/eurheartj/ehz405. View

3.
Vedovati M, Becattini C, Agnelli G, Kamphuisen P, Masotti L, Pruszczyk P . Multidetector CT scan for acute pulmonary embolism: embolic burden and clinical outcome. Chest. 2012; 142(6):1417-1424. DOI: 10.1378/chest.11-2739. View

4.
Jain C, Chang Y, Kabrhel C, Giri J, Channick R, Rodriguez-Lopez J . Impact of Pulmonary Arterial Clot Location on Pulmonary Embolism Treatment and Outcomes (90 Days). Am J Cardiol. 2017; 119(5):802-807. DOI: 10.1016/j.amjcard.2016.11.018. View

5.
Irmak I, Sertcelik U, Oncel A, Er B, Inam G, Durhan G . Correlation of thrombosed vessel location and clot burden score with severity of disease and risk stratification in patients with acute pulmonary embolism. Anatol J Cardiol. 2020; 24(4):247-253. PMC: 7585957. DOI: 10.14744/AnatolJCardiol.2020.55013. View